Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100381

PubMed Identifier: 35434685

Publication URI: http://europepmc.org/abstract/MED/35434685

Type: Journal Article/Review

Volume: 17

Parent Publication: The Lancet regional health. Europe

ISSN: 2666-7762